Sandoz Group AG ADR (SDZNY)

Profile

https://www.sandoz.com

Sandoz Group AG ADR represents the American Depositary Receipts for Sandoz Group, a global leader in generic pharmaceuticals and biosimilars. As the generics division spun off from Novartis, Sandoz focuses on providing cost-effective and high-quality pharmaceutical alternatives, significantly impacting healthcare by increasing accessibility to essential medicines. Sandoz specializes in various therapeutic areas, including cardiovascular diseases, oncology, and anti-infectives, offering a diverse product portfolio across multiple geographies. This financial asset allows U.S. investors to own shares in Sandoz Group AG without trading on European exchanges. The ADRs facilitate investment by simplifying currency exchange processes and providing easier access to the company’s financial performance reports. Sandoz plays a critical role in the pharmaceutical industry by driving down healthcare costs and encouraging competition through innovation in generic drugs and biosimilars. The company's activities and market reach underscore its influence in enhancing medication availability and addressing unmet medical needs globally.